Case Study Highlights Tardive Dyskinesia and the Importance of Early Diagnosis and Treatment
Researchers of a study assessed tardive dyskinesia (TD). TD is primarily caused by medication use, particularly neuroleptic drugs, and can affect approximately 2% to 5% of patients annually.
Study Uncovers Neural Network Vulnerability in Tardive Dyskinesia’s Orofacial Symptoms
In a recent study, researchers aimed to understand why tardive dyskinesia (TD) often exhibits orofacial symptoms, while also exploring the neural network involved.
Addressing Prevalence of Tardive Dyskinesia in Long-Term Care Residents: Strategies for Improved Quality of Life and Effective Treatment
This course is designed for long-term care clinicians, including medical directors, physicians, nurse practitioners, physician associates, pharmacists, and psychiatrists, as well as other health professionals caring for older adults.
Understanding and Managing Extrapyramidal Effects Caused by Antipsychotic Medications
Researchers of a study explored the pathophysiology of extrapyramidal effects (EPS) caused by antipsychotic medications, including the delicate balance between therapeutic effects and extrapyramidal effects.
